Present study explores the role of NADPH quinone oxidoreductase 1 (NQO1) C609T (Pro187Ser) polymorphism in susceptibility to and its probable role in malignant potentiality of Oral submucous fibrosis (OSF) -a debilitating disease caused mainly by chewing arecanut.
Introduction
Oral cancer (OC) is increasing at an alarming rate and it is the 11th most common cancer in the world. Out of this large number, two-third cases are recorded in developing countries. Late diagnosis of potential precancerous lesions is considered as the major cause of such higher incidence (1).
Upsurge in the popularity of commercially prepared areca nut preparations (popularly known as 'panmasala'), an increased uptake of this habit by young people easy access, effective price ranges and marketing strategies have contributed to a high prevalence of smokeless tobacco related oral carcinogenesis in India (2, 3) . Chewing of tobacco with betel quid increases the concentrations of carcinogenic tobacco specific nitrosamines and reactive oxygen species in mouth (3) as an early sign of damage to oral mucosa, tobacco smokers and chewers often develop precancerous oral lesions such as leukoplakia and submucos fibrosis.
Oral submucous fibrosis (OSF) is an insidious, chronic, progressive precancerous condition of the oral cavity and oropharynx with a high degree of malignant potentiality. A significant number of this precancerous condition converts into Oral Squamous Cell Carcinoma (OSCC), the rate being about 7.4-13% (4). This disease is now a public health concern in many parts of the world including United Kingdom, South Africa and many southeast Asian countries though it is mainly prevalent in the Indian subcontinent in all age groups and across all socioeconomic strata. (5) (6) (7) (8) .
The human NAD(P)H:quinone oxidoreductase 1 gene (NQO1; DT-diaphorase, Enzyme Commission (EC) number 1.6.99.2 ) occupies 17 kilobase pairs (kb) within a gene-rich region on chromosome 16 at 16q22.1 (9) . This cytosolic flavoenzyme detoxifies quinones (a large class of aromatic compounds found commonly in plants, benzene metabolites, and chemotherapies) to hydroquinones or catechols. The enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1) acts as an antioxidant by catalyzing a 2-electron reduction that bypasses the need for two 1-electron reductions that can result in the production of DNA and protein-damaging reactive oxygen species. In certain conditions (e.g., the presence of myeloperoxidase or autooxidants), NQO1 can contribute to the formation of reactive oxidation species via oxidative cycling and therefore can act as a prooxidant (10) . NQO1 is constitutively expressed in most tissues including the bone marrow, where expression is thought to be highly inducible by xenobiotics with quinone moieties, and is upregulated during times of oxidative or electrophilic stress. NQO1 expression is also upregulated in tumor tissues as the result of hypoxia (11) : The success of quinone-based chemotherapies to exert their cytotoxic effects depends on their bioactivation by elevated levels of NQO1. Other than its implication in protection against oxidative stress and carcinogenesis (12, 13) , it also includes stabilization of the p53 (14-17) a tumor suppressor gene.
The polymorphisms of NQO1gene have been characterized and known for about two decades (17) . Of which a C-to-T substitution at position 609 of NQO1 cDNA, which codes for a prolineto-serine change at residue 187 is now well studied in most cancers. In cells with a TT Genotype NQO1 activity is not detected and lack of activity corresponds to a lack of NQO1 protein which undergoes rapid turnover via the ubiquitin mediated proteasomal degradation pathway (18) . The prevalence of the TT genotype varies among ethnic groups (4-20%), with the highest prevalence occurring in Asian populations (19, 20) .
Previously it has been demonstrated that NQO1 through a distinct pathway stabilizes p53 -a well-known tumor suppressor, through induction of apoptosis at the G1/S checkpoint (21) . On the other hand Cyclin D1 plays a central role in the G1/S cell cycle transition and responses to cytotoxic stimuli. In addition cyclin D1 has been observed to be highly upregulated in oral cancer tissues (22) . In the current study, we investigated that NQO1 Ser/Ser minor allele has a major role in increasing risk of developing OSF and plays a central role in triggering oral carcinogenesis in the affected tissue. Our observation also includes the response of NQO1 towards areca chewing mucosa of OSF patients and the effect of these genotypes in such response. We have also demonstrated that NQO1 by stabilizing p53(Ser15) from MDM2 mediated degradation regulates cyclinD1 expression in mucosal tissue. p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro (23, 24) . DNA damage induces phosphorylation of p53 at Ser15 and leads to a reduced interaction between p53 and its negative regulator, the oncoprotein MDM2 (25) . MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation (26, 27) . Phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and activation of p53 in response to DNA damage (25, 28) , thus making phosphorylated p53 (ser15) as an unique marker for oxidative stress generated DNA damage.
Materials and Methods

Patients and controls:
A total of 179 patients with newly diagnosed cases of oral submucous fibrosis and 152 healthy control subjects having oral habit for a similar period were recruited from out patients department at Dr. R Ahmed Dental College & hospital, Kolkata, India over a 3year period. All individuals enrolled in the study provided informed consent for their participation in the study. All participants completed a questionnaire providing information about their age, gender, ethnic origin, and use of panmasala & gutkha, smoking status or alcohol.
Blood was collected from the antecubital vein, while biopsy sample was collected from the affected tissue after obtaining a written consent was obtained from all the patients after educating them about the importance and outcome of the study. All the study protocols were reviewed by an institutional ethical committee, and samples were collected by medical trained professionals.
A part of the tissue was used for routine histopathological and immunohistochemical examination, while another part was used for further analysis of genetic or protein expression. lines that do not overlap or criss-cross, are not elevated and radiate from a central erythematous area) were selected. Comet assay was performed and analyzed as described previously (31) .
Statistical analysis:
The calculation of genotypic and allele frequencies for cases and controls and association between polymorphisms of NQO1 C609T with the risk of oral submucous fibrosis among total and stratified population was estimated by computing Odds ratio (OR) and calculating 95% Confidence Interval (CI) using a chi-square Table Analysis and Yates corrected P value was taken for significance.
The expression of NQO1 protein was analyzed densitometricaly using Image J software after proper calibrations. The difference in protein expression was analyzed by Student "t" test, p value <0.05 was considered to be significant.
Results:
The total study population was stratified according to Gender (Male and Female), Median age (40 years), Inter-incisal distance (ID) as Grade I (ID>3cm), Grade II (ID 2-3cm), Grade III (ID<2cm) & Habit and are presented in Table 1 . We found that male (65.9%) constituted a greater percentage of the study sample and that most of the OSF cases were in the age group of > 40 years (65.9%). When the total OSF cases were divided according to interincisal distance as grade I, II and III, maximum distribution was found for grade II (61.4%).
Distribution of Genotypes of NQO1 C609T polymorphism among the cases and controls:
After PCR-RFLP analysis of the study samples (cases and control), the distribution of genotypes -Wild type C/C allele, heterozygous C⁄T allele and homozygous mutant T/T alleles were observed in the stratified study population and different grades of OSF and are presented in 
NQO1 expression and epethilial DNA disintegration in different genotypes:
An overall mRNA expression level was higher in patients with either genotype compared to controls indicating transcriptional up regulation of NQO1 in tissues ( Figure 1A) . In general a significantly decreased mean expression for NQO1 protein was observed in buccal mucosal tissues of patients having heterozygous (42%) or homozygous (70%) mutant conditions (p=0.0055 & p=0.0001 respectively) indicating NQO1 degradation in homozygous / heterozygous mutant patients is a post-transcriptional event ( Table 4 ) ( Figure 1B ).
Histochemical localization of NQO1 protein in oral epithelial cells ( Figure 1C) is concurrent with western-blots and shows high concentrations of NQO1 expression in epithelium of the tissue sections obtained from OSF patients with wild type Pro/Pro genotype compared to almost focal expression in normal healthy epithelium. Sections show increased NQO1 expression around the basal cell layer in wild type trait. NQO1 expression in OSF patients with heterozygous trait showed faint localizations whereas patients with homozygous mutant trait showed almost no NQO1 expression in the basal cells or elsewhere.
Comparative DNA damage of OSF with other oral precancerous lesions from our previous study (31) and according to genotype in this study presents a general disintegrated DNA in patients with wild type genotype and this worsens with heterozygous or homozygous conditions ( Figure   1D ). Asian populations (19) . In the present study, we observed a significantly higher number of subjects carrying the NQO1 homozygous mutant allele genotype in patients suffering from oral submucous fibrosis as compared to the control group. Mostly male patients with OSF reported to our outpatient department (OPD) compared to the female patients, and middle-aged/old patients (>40yrs) showed a greater association with the risk of the disease. This result is in line with previous investigations that showed an association between the NQO1 homozygous mutant genotype and other tumour types such as urothelial cancer, renal cancer, leukemias, lung cancer and cutaneous basal cell carcinoma (32) (33) (34) (35) (36) . The mechanism underlying the correlation of NQO1 C609T polymorphism with the increased risk for developing various tumours likely resides in the different enzyme activities encoded by the NQO1 alleles. A case-control study of benzene exposed workers in China revealed increased risk of hematotoxicity in individuals with the T/T NQO1 genotype, suggesting that NQO1 protects against benzene toxicity.
Lower NQO1 activity in OSF and
The current study suggests that NQO1 C609T null allele acts in a recessive mode in the development of OSF, demonstrated by the fact that the heterozygous genotype frequency among OSF patients remains similar to that among the healthy controls. This indicates that in individuals with the NQO1 heterozygous genotype, the enzyme activity might be sufficient for protecting cells from damage by exogenous carcinogens important for the development of OSF.
The determination of the NQO1 C609T genotype may be valuable as a stratification marker in future intervention trials for OSF and oral squamous cell carcinoma (OSCC). This finding may be particularly important in our country as most of the common people are habituated to areca chewing in different modes and are susceptible to development of OSF and eventually OSCC.
Moreover since NQO1 C609T polymorphism was found to be positively associated with many solid as well as blood malignancies, therefore, a practical approach for cost-effective tumour In a previous study Asher et al (15) followed by Anwar et al (37) demonstrated NQO1 plays a mojor role in stabilising p53 either by redox mechanism or by formation of any multiprotein complex. The p53 gene is one of the major tumor suppressor genes in humans. In case of oxidative stress induced DNA damage p53 is phosphorylated at Ser15 and Ser20 and leads to a reduced interaction between p53 and its negative regulator, the oncoprotein MDM2. MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation.
Phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and activation of p53 in response to DNA damage. The p53 gene regulates cell cycle progression through induction of apoptosis at the G1/S checkpoint. Another key sensor protein that regulates cell cycle in early to mid-G1 phase is cyclin D1. Cyclin D1 is sequentially phosphorylated by cyclin E/CDK2 and inhibit the retinoblastoma protein (pRb) which in turn inactivate the cellcycle inhibiting function and thus increase DNA synthesis (21) . Overexpression of cyclin D1 is being observed in oral cancers (22) and increase risk of tumor progression and metastasis in precancerous tissues.
An upregulated phospho p53 (ser15) in oral submucous fibrosis tissues is an indicator of oxidative stress generated DNA repair mechanism, in wild type NQO1 (Pro/Pro) phospho p53 (ser15) was observed to be stabilized with lesser expression of cyclin D1 suggestive of less carcinogenic risk in these patients. One of very interesting observation which led to this study was that a total of 10 OSF patients out of 179 during the last three year study, was found to of NQO1 C609T polymorphism and carcinogenic turnover of a precancerous lesion and the possible mechanism is presented as a model (Figure 3 ). The upregulated expression of CCND1 in either heterozygous or homozygous patients is very distinct, and will need further experimentation to explain such observation. Oral submucous fibrosis, which has an etiology of chewing areca nut with tobacco, has high cancer turnover potency.
Presently oral cancers are increasing at an alarming rate and have an increasing mortality rate particularly in this part of the world, may serve as an excellent model to study various interactions of proteins in carcinogenic turnover in the light of presence of different deleterious polymorphisms. This study sets an example why the polymorphic status of a patient should also be taken into account before designing oral cancer therapeutics targeting these pathways. To conclude, NQO1 not only serves as an antioxidant enzyme but also functions as a tumor suppressor, and can have an important prognostic value. 
